Friday, July 10, 2026

pharma · Stargardt Disease · Muscle Relaxation · ELTP

ELITE PHARMACEUTICALS INC

ELITE PHARMACEUTICALS INC is a pharma organization headquartered in Northvale, USA. It trades on NYSE under ticker ELTP. Primary therapeutic focus areas include Stargardt Disease, Muscle Relaxation, Geographic Atrophy, D

Northvale, USA HQ
1996 Founded
64 Employees
Public company Type
ELTP · NYSE Ticker
Company details
Clinical program

Tinlarebant 5 mg´s matching Placebo, LBS-008

Phase 3 · small molecule · Stargardt Disease

Tinlarebant 5 mg´s matching Placebo, LBS-008 for Stargardt Disease is a Phase 3 program (small_molecule) at ELITE PHARMACEUTICALS INC /NV/ with 1 ClinicalTrials.gov record(s).

Internal code LBS-008-CT03

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
ELITE PHARMACEUTICALS INC /NV/
Phase
Phase 3
Modality
small_molecule
Indication
Stargardt Disease
Status
active
Trials
1